Pooled Population Pharmacokinetic Analysis and Dose Recommendations for Ciprofloxacin in Intensive Care Unit Patients with Obesity

医学 药代动力学 加药 人口 肾功能 重症监护室 肥胖 分配量 药效学 环丙沙星 内科学 重症监护医学 抗生素 环境卫生 微生物学 生物
作者
Koen P. van Rhee,Roger J. M. Brüggemann,Jason A. Roberts,Fredrik Sjövall,Reinier M. van Hest,Paul Elbers,Alan Abdulla,Paul D. van der Linden,Catherijne A. J. Knibbe
出处
期刊:The Journal of Clinical Pharmacology [Wiley]
卷期号:64 (9): 1165-1172
标识
DOI:10.1002/jcph.2450
摘要

Abstract Recent studies have explored the influence of obesity and critical illness on ciprofloxacin pharmacokinetics. However, variation across the subpopulation of individuals with obesity admitted to the intensive care unit (ICU) with varying renal function remains unexamined. This study aims to characterize ciprofloxacin pharmacokinetics in ICU patients with obesity and provide dose recommendations for this special population. Individual patient data of 34 ICU patients with obesity (BMI >30 kg/m 2 ) from four studies evaluating ciprofloxacin pharmacokinetics in ICU patients were pooled and combined with data from a study involving 10 individuals with obesity undergoing bariatric surgery. All samples were collected after intravenous administration. Non‐linear mixed effects modeling and simulation were used to develop a population pharmacokinetic model and describe ciprofloxacin exposure in plasma. Model‐based dose evaluations were performed using a pharmacokinetic/pharmacodynamic target of AUC/MIC >125. The data from patients with BMI ranging from 30.2 to 58.1 were best described by a two‐compartment model with first‐order elimination and a proportional error model. The inclusion of Chronic Kidney Disease Epidemiology Collaboration (CKD‐EPI) as a covariate on clearance reduced inter‐individual variability from 57.3% to 38.5% ( P < .001). Neither body weight nor ICU admission significantly influenced clearance or volume of distribution. Renal function is a viable predictor for ciprofloxacin clearance in ICU patients with obesity, while critical illness and body weight do not significantly alter clearance. As such, body weight and critical illness do not need to be accounted for when dosing ciprofloxacin in ICU patients with obesity. Individuals with CKD‐EPI >60 mL/min/1.73 m 2 may require higher dosages for the treatment of pathogens with minimal inhibitory concentration ≥0.25 mg/L.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
OK给tony的求助进行了留言
刚刚
十个勤天完成签到,获得积分10
刚刚
小二郎的应助被张煜禾采纳,获得10
刚刚
12581发布了新的文献求助10
刚刚
优美煎蛋发布了新的文献求助10
刚刚
iuwallace发布了新的文献求助10
1秒前
milion完成签到,获得积分10
1秒前
1秒前
1秒前
YitingW发布了新的文献求助10
1秒前
1秒前
研友_nVj3yn发布了新的文献求助10
1秒前
斯文败类的应助被chuhan采纳,获得10
1秒前
gela发布了新的文献求助10
2秒前
bkagyin的应助被我爱玩原神采纳,获得10
2秒前
汉堡包的应助被Ma采纳,获得10
2秒前
Ava的应助被wu采纳,获得10
2秒前
李元发布了新的文献求助10
2秒前
zzl发布了新的文献求助10
3秒前
Maestro_S的应助被职克琪采纳,获得10
3秒前
隐形曼青的应助被职克琪采纳,获得10
3秒前
3秒前
zxy发布了新的文献求助10
3秒前
甜美的兔子完成签到,获得积分10
4秒前
4秒前
accepted完成签到,获得积分10
4秒前
传奇3的应助被愤怒的水壶采纳,获得10
4秒前
SciGPT的应助被lawliet采纳,获得10
4秒前
小零完成签到,获得积分10
4秒前
Maestro_S的应助被h11采纳,获得10
4秒前
jhlllllll发布了新的文献求助10
4秒前
董文强发布了新的文献求助10
5秒前
5秒前
5秒前
清风明月发布了新的文献求助10
5秒前
迷了路的猫完成签到,获得积分10
6秒前
6秒前
jonghuang发布了新的文献求助10
9秒前
赘婿的应助被window1000采纳,获得10
9秒前
贤君发布了新的文献求助10
9秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
What Else Can I Tell You?: A Pragmatic Study of English Rhetorical Questions as Discursive and Argumentative Acts 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8164445
求助须知:如何正确求助?哪些是违规求助? 9558283
关于积分的说明 21744871
捐赠科研通 7754979
什么是DOI,文献DOI怎么找? 3428582
关于科研通互助平台的介绍 2553119
邀请新用户注册赠送积分活动 2473142